BioPharma Dive

JULY 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Dive Brief Actithera draws new investors to radiopharma drug pitch The four-year-old biotech raised about $75 million in a Series A round that involved nine venture capital firms.

Drug Pricing 60

Drug Pricing Compounding Immunity Immunization 60

Pharmaceutical Commerce

JUNE 18, 2025

How Recent Executive Orders Impact the Drug Pricing Landscape Nicholas Saraceno, Editor May 30th 2025 Podcast Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Pharmacy Technician Pharmaceutical Companies 52

PharmaVoice

JUNE 16, 2025

Kevin Dietsch via Getty Images Listen to the article 8 min This audio is auto-generated. Known as the negotiators between health plans, pharmacies and drug companies, pharmacy benefit managers are currently entangled in a national conversation about reform. This replaces the average wholesale price benchmark, which is more opaque.

Drug Pricing 306

Drug Pricing Independent Pharmacies Community Pharmacies Drug Development 306

Pharmacy Times

JUNE 23, 2025

This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs. 505(b)(2) drugs: new chaos for infusion centers. REFERENCE Soefje SA.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Putting Patients First Blog

MAY 6, 2025

Food and Drug Administration, Importing Biologics and CBER Regulated Products. 15 Bharath Krishnamurthy and Megha Parikh, Drug Prices and Shortages Jeopardize Patient Access to Quality Hospital Care, AHA News , May 22, 2024, https ://www.aha.org/news/blog/2024-05-22-drug- prices-and-shortages-jeopardize-patient-access-quality-hospital-care.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Generic Medicine Drug Pricing Hospitals 52

Pharmacy Times

JUNE 16, 2025

According to Trump, patients could see cost reductions of 30% to 80%, but experts question the feasibility and practicality of implementing such a policy within the complex United States drug pricing and supply system. Kennedy Jr, is permitted to develop a new rule that ties American drug prices to those of other nations.

Pharmacy Technician 26

Pharmacy Technician Drug Pricing Insurance Coverage and Processing Compounding Pharmacies 26

Pharma Marketing Network

APRIL 28, 2025

This article dives deep into why 2025 will mark a pivotal moment for pharma marketing and how savvy brands can stay ahead. The Inflation Reduction Act and new drug pricing regulations are pushing pharmaceutical companies to justify value more transparently.

Communication 59

Communication Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Marketing Network

MAY 11, 2025

accelerates its crackdown on drug pricing through new legislation and regulatory enforcement, pharma companies in China, India, Japan, and South Korea are feeling the ripple effect. This article explores whats behind the sudden slump in Asian pharmaceutical equities and why U.S. As the U.S. Table of Contents The U.S.

Drug Pricing 59

Drug Pricing Biosimilars Communication Pharmaceutical Companies 59

Pharmaceutical Commerce

JUNE 17, 2025

Therapeutic Drug Use. link] Download Issue PDF Articles in this issue Bolstering Health Technology Assessment With the Help of AI Changing the PAP Model Building Intelligent Pharma Supply Chain Management with Real-World Data Policy Whiplash? References 1. FDA at a Glance.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Coverage and Processing Hospitals Drug Pricing 52

Pharmaceutical Commerce

JUNE 9, 2025

How Recent Executive Orders Impact the Drug Pricing Landscape Nicholas Saraceno, Editor May 30th 2025 Podcast Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Drug Pricing 52

Drug Pricing Vaccines Immunity Immunization 52

Pharmaceutical Commerce

JUNE 23, 2025

3 M&A activity cools under policy pressure As of now, M&A activity is currently in a holding pattern due to the aforementioned US drug pricing and tariff uncertainty. Deals have evolved in the sense that they now include lower upfront payments, and structures that are much more milestone-heavy.

Drug Pricing 52

Drug Pricing Compounding 52

Pharmaceutical Technology

JUNE 9, 2025

In this article, GlobalData investigates key reimbursement trends that reflect the current delays to patient access across the European region. Alex Watt June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The delays in market access in individual EU member states have been an obstacle to the industry.

Communication 52

Communication Hospitals Drug Pricing Packaging 52

Pharmaceutical Commerce

JUNE 16, 2025

24 Hours in the Hub Still Matters More June 16, 2025 By Chris Dowd, ConnectiveRx Commentary Article Pharmaceutical Commerce Pharmaceutical Commerce - June 2025 Volume 20 Issue 3 Doubling down on patient access and support fundamentals will win out over Washington’s next move. Articles in this issue Policy Whiplash?

Insurance Coverage and Processing 52

Insurance Coverage and Processing Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 52

PharmaVoice

JUNE 16, 2025

The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight. Published June 16, 2025 By Kelly Bilodeau post share post print email license Stock via Getty Images Listen to the article 9 min This audio is auto-generated.

Hospitals 214

Hospitals Mail-Order Pharmacies Drug Pricing Pharmaceutical Companies 214

Proxsys Rx

APRIL 1, 2025

Regardless of your answer, theres no question the 340B Drug Pricing Program remains a critical resource for eligible healthcare providers, enabling them to stretch scarce federal resources to provide essential services to underserved communities.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Documentation Drug Pricing 52

BioPharma Dive

JUNE 26, 2025

Most Popular FDA investigating Elevidys safety; Nektar shares spike on eczema data Kymera adds Gilead as research partner, while advancing new candidate with Sanofi Oz hints at impending CMS rule to force drug price transparency Hundreds of laid-off HHS staff have been reinstated, RFK Jr. You can unsubscribe at anytime.

Drug Pricing 43

Drug Pricing Immunity Immunization Drug Development 43

BioPharma Dive

JUNE 9, 2025

Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

BioPharma Dive

JULY 14, 2025

Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales.

Drug Pricing 73

Drug Pricing Drug Development Vaccines 73

Pharmaceutical Commerce

JULY 16, 2025

How Recent Executive Orders Impact the Drug Pricing Landscape. Development & Approval Process | Drugs. US Food & Drug Administration. Justin Kozak The buzz around GLP-1 agonists like Ozempic and Wegovy is undeniable, fueled by social media virality and impressive clinical results. References 1. Health Prem.

Compounding 69

Compounding Insurance Coverage and Processing Drug Pricing Compounding Pharmacies 69

Pharmaceutical Technology

JULY 4, 2025

There has been a push by the Trump administration to increase biosimilar and generic drug use in the US. In May 2025, the US president signed an executive order that overhauled pharmaceutical pricing in the country. How will RFK Jr’s American dream for vaccines play out?

Biosimilars 52

Biosimilars Chemotherapy Packaging Communication 52

Pharmacy Times

JUNE 12, 2025

Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” with the objective of lowering drug prices, namely on branded drug products, for American consumers. How Does Drug Pricing in the US Compare With Other Countries? REFERENCES 1.

Pharmacy Technician 26

Pharmacy Technician Community Pharmacies Drug Pricing Hospitals 26

BioPharma Dive

JUNE 27, 2025

Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales.

Drug Pricing 70

Drug Pricing Hospitals Immunity Immunization 70

Pharma Marketing Network

APRIL 20, 2025

This article explores the nuances of how this label affects pharmaceutical marketing and what brands can do to respond strategically. Criticisms typically revolve around drug pricing, lobbying influence, and perceived lack of access in underserved communities.

Labelling 52

Labelling Communication Drug Pricing 52

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

Pharmaceutical Technology

JUNE 18, 2025

Amid President Donald Trump’s stated desire to sharply reduce drug prices on the US market, India has also proposed to supply generic medicines at between 20% and 25% of the current reference branded prices, for three years after originator patent expiry.

Drug Pricing 52

Drug Pricing Communication Pharmaceutical Companies Pharmaceutical Companies 52

BioPharma Dive

JULY 16, 2025

Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales.

Drug Pricing 120

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Labelling 120

Pharmaceutical Commerce

JULY 10, 2025

Jacqueline Durett Few times in the evolution of a pharmaceutical company are as exciting as during the flurry of launch readiness activities focused on bringing a new drug to market.

Communication 87

Communication Drug Pricing Medical Schools Hospitals 87

BioPharma Dive

JULY 2, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Dive Brief Organon drug for endometriosis falls short in mid-stage study Company executives had seen the drug as a potential multi-billion dollar opportunity in women’s health.

Drug Pricing 96

Drug Pricing Drug Development Vaccines 96

Pharma Marketing Network

MAY 14, 2025

drug prices align with those in countries like Canada or the UK. This move seeks to reduce prescription drug costs by up to 80%, introducing significant changes to the pharmaceutical landscape. drug prices match the lowest prices available in other developed countries. approach to pharmaceutical pricing.

Drug Pricing 59

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Communication 59

Pharmaceutical Commerce

JUNE 13, 2025

The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by certain OECD countries—an approach previously blocked by courts. Concerns over price controls. What is MFN model pricing?

Drug Pricing 59

Drug Pricing Biosimilars Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Commerce

JUNE 18, 2025

Drugs of all kinds are getting smarter, resulting in growth opportunities for all types of pharmaceuticals, blending the line between pharmaceutical drugs and medical devices,” wrote Stephen Robinson, sales engineer with Coesia North America in an article 2 for Pharma Commerce.

Drug Pricing 52

Drug Pricing Packaging Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Commerce

JUNE 12, 2025

link] Recent Videos Related Content Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season Nicholas Saraceno, Editor June 9th 2025 Article In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date. Serialization 2.0: Why It’s Time to Upgrade, and What’s at Stake John F.

Drug Pricing 52

Drug Pricing 52

BioPharma Dive

JUNE 26, 2025

Most Popular FDA investigating Elevidys safety; Nektar shares spike on eczema data Kymera adds Gilead as research partner, while advancing new candidate with Sanofi Oz hints at impending CMS rule to force drug price transparency Hundreds of laid-off HHS staff have been reinstated, RFK Jr. You can unsubscribe at anytime.

Drug Pricing 46

Drug Pricing Drug Development Vaccines 46

Pharmaceutical Commerce

JUNE 18, 2025

June 18th 2025 Article The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges. Click here to view our interactive June 2025 issue! Related Content The Art of Agility Mike Hennessy Jr.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JULY 2, 2025

Advocates for the agency argue that while the opposing approach would streamline drugmakers’ access to the local market, it would not affect drug pricing, improve pharmacovigilance, bolster local manufacturing capacity or advance specific public health priorities. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Drug Pricing Communication Hospitals 52

PharmaVoice

JUNE 11, 2025

Published June 11, 2025 Amy Baxter Staff Reporter post share post print email license Win McNamee via Getty Images Listen to the article 5 min This audio is auto-generated. Currently, the program exempts orphan drugs from price negotiations if they only have one indication for rare disease. Will Trump and the GOP make the leap?

Drug Pricing 179

Drug Pricing Packaging Documentation 179

BioPharma Dive

JUNE 24, 2025

Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales.

Drug Pricing 87

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Packaging 87